Connect with us

NEWS

Experimental drug effective on monkeys

Published

on

REMDESIVIR drug has shown strong signs of being effective for treatment of Coronavirus.

  This follows laboratory tests conducted on infected monkeys with remdesivir drug which showed significant improvement on the animals’ recovery in just 12 hours after the first treatment.

  This was disclosed in a press release by the US National Institutes of Health which stated that the antiviral drug remdesivir has proven effective in treating monkeys infected with COVID-19.

  “Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19, according to the scientists that ran the experiment.

  The small study, which is preliminary and has yet to be peer-reviewed, mimicked treatment procedures that are being used in a large human trial conducted on patients who have been hospitalized with either the COVID-19 disease or the SARS-CoV-2 virus.”

  Remdesivir is reported to work against the COVID-19 by adding mutations that ultimately destroy the virus.

  According to the researchers’ findings from the experiment with monkeys, “two groups of six rhesus macaques were intentionally infected with the respiratory virus. The test group was treated with the drug, developed by Gilead Sciences, while the untreated comparison group was not.

  The test group was given its first dose of the drug intravenously 12 hours after the initial infection, then every day for the next six days. The first treatment was timed to occur just before the virus reached its maximum level in the monkeys’ lungs.

  Twelve hours after the first treatment, the macaques’ symptoms had significantly improved. Their conditions continued improving over the week.

  At the end of the test phase, just one of the six treated animals displayed mild difficulty breathing, while all six animals in the untreated group had difficulty breathing.

  The treated group also displayed significantly lower levels of the virus in their lungs than the untreated group and also had less lung damage.”

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending